Synpromics has developed a more efficient means of designing promoters that can be used in processes such as insulin production.

Synpromics' technology is an example of an enabling technology; by developing promoters specific to particular tissues, new products can be developed.

Synthetic promoters are DNA sequences that do not exist in nature and which are designed to regulate the activity of genes, controlling a gene’s ability to produce its own uniquely encoded protein.

Synpromics improves on viral promoters by increasing the yield of protein production and by increasing specificity and reliability of the promoters.

Read some of the most frequently asked questions on Synpromics technology